Professor Sarah Robertson is a graduate of the University of Adelaide (BSc 1983; PhD 1993). She returned to Adelaide after periods at the University of Alberta (Edmonton, Canada) and University of Gothenburg (Sweden). She was an NHMRC Principal Research Fellow until appointment to Director of the Robinson Research Institute in October 2013, after 18 years in the NHMRC Fellowship scheme.
Her research focus is mammalian reproduction and development, particularly immune regulation of fertility and pregnancy. She strives to advance understanding of the fundamental biology of conception, embryo implantation and early development, and to apply this to develop new approaches for managing infertility and pregnancy disorders. She partnered with Origio A/S to develop EmbryoGen, a novel immune-based intervention for repeated IVF failure and recurrent miscarriage now sold in >50 countries worldwide, and is funded by Ferring Pharmaceuticals and other industry partners to investigate novel strategies to tackle miscarriage, preeclampsia and preterm delivery.
She is an elected Fellow of the Australian Academy of Science (2016) and the Australian Academy of Health and Medical Sciences (2015), and a Fellow of the Society for Reproductive Biology (2011).
Her work is funded by the National Health and Medical Research Council of Australia, the Australian Research Council, the Canadian Institutes of Health Research, and the Channel 7 Children's Medical Research Foundation. Her research output includes more than 200 peer-reviewed scientific journal papers and reviews in high impact journals, >20 book chapters and 4 patent families. Her H-index is 67 with >13,000 citations (Google Scholar).
She serves in professional roles for the NHMRC, Australian Academy of Science, Australian Academy for Health and Medical Science, Association of Australian Medical Research Institutes, Ramaciotti Foundations, Channel 7 Children's Medical Research Foundation, International Society for Immunology of Reproduction, and US Society for the Study of Reproduction.
She collaborates extensively with colleagues in Australia and around the world and has supervised 30 PhD students (24 completed) plus 39 Honours students. For the period of 2008-2013 she was Editor-in-Chief of the Journal of Reproductive Immunology and now serves on the Editorial Boards of Endocrinology, Immunology and Cell Biology, and Clinical and Translational Immunology, as well as the Board of Consulting Editors of the Journal of Clinical Investigation. She regularly contributes to peer review for the NHMRC, ARC, and many international funding agencies.